Navigation Links
Landmark Legal Foundation to File Suit to Stop President's Health Plan if 'Slaughter Rule' is Used
Date:3/17/2010

LEESBURG, Va., March 17 /PRNewswire-USNewswire/ -- Mark R. Levin, president of Landmark Legal Foundation, today issued a warning to the leadership of the U.S. House of Representatives about the possible use of the so-called "deem and pass," "self-executing," or "Slaughter Rule" to enact H.R. 3590, the legislative version of President Obama's healthcare proposal that has been previously approved by the Senate. If this tactic is employed, Landmark will immediately sue the President, Attorney General Eric Holder and other relevant cabinet members to prevent them from instituting this unconstitutional contrivance.

"Landmark has already prepared a lawsuit that will be filed in federal court the moment the House acts. Such a brazen violation of the core functions of Congress simply cannot be ignored. Article I, Section 7 of the Constitution is clear respecting the manner in which a bill becomes law. Members are required to vote on this bill, not claim they did when they didn't. The Speaker of the House and her lieutenants are temporary custodians of congressional authority. They are not empowered to do permanent violence to our Constitution."

(A draft of the complaint Landmark will file is available at http://www.landmarklegal.org.)

Founded in 1976, Landmark Legal Foundation is a nonprofit, public interest law firm with offices in Kansas City, Missouri and Leesburg, Virginia.

SOURCE Landmark Legal Foundation

Back to top

RELATED LINKS
http://www.landmarklegal.org

'/>"/>

SOURCE Landmark Legal Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Foodborne Illness Costs U.S. $152 Billion Annually, Landmark Report Estimates
2. California to Examine Health Impacts of Landmark Cap-and-Trade Program
3. New edition of landmark stroke textbook
4. Landmark Textbook Aims to Improve Clinician, Consumer Understanding of Lesbian Health
5. Senate Passes Landmark Health Care Reform Bill
6. DNC Chairman Tim Kaine Calls Senate Vote Historic, Says Landmark Health Reform Bill Is a Victory for the American People
7. 59 percent support Massachusetts Landmark 2006 health reform law
8. Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcanos VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks
9. Are You Connected? AIM and GASICORP Expand Global Reach Through Landmark Strategic Alliance
10. GMA Applauds U.S. House for Passage of Landmark Food Safety Bill
11. Sodexo Offers Landmark Program to Promote Employee Health and Worklife Balance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... , ... December 06, 2016 ... ... on Friday, November 25th, when SevenPoint2 released the much-anticipated HydroFX for Water®. ... eye-catching label design. Featuring one of the world’s most powerful antioxidants, molecular ...
(Date:12/6/2016)... ... December 06, 2016 , ... TopConsumerReviews.com recently gave a ... Scooters . , Mobility Scooters give freedom to people who need help getting around. ... may be facing a long period of rehabilitation after an illness or accident. There ...
(Date:12/5/2016)... ... December 05, 2016 , ... "FCPX Overlay Glare is a ... lighting effect without heavy rendering or complicated compositing," said Christina Austin - CEO of ... create an organic spectrum of lights that simulates the look of a glare. ...
(Date:12/5/2016)... GA (PRWEB) , ... December ... ... technology and security executive networking and relationship-marketing firm, announced today that nominations ... the 2017 Information Security Executive® (ISE®) Central Awards. , Awards include the ...
(Date:12/5/2016)... ... December 05, 2016 , ... Physicians Education ... Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma, on ... “We are honored to have Amy E. Herman present at this year’s conference, ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec. 5, 2016   Lexicon Pharmaceuticals, ... results today from a Phase 2 clinical study of ... Lexicon in collaboration with JDRF, the leading global organization ... of this Phase 2 clinical trial, which randomized a ... of a once-daily 400 mg dose of sotagliflozin compared ...
(Date:12/5/2016)... , December 5, 2016 According to ... Treatment modalities (Chondrocyte Transplantation, Growth Factor Technology, Tissue Scaffolds, Cell-free composites), ... by MarketsandMarkets, the market is projected to reach USD 779.8 Million ... CAGR of 13.5% during the forecast period of 2016 to 2021. ... ...
(Date:12/5/2016)... PORTLAND, Oregon and PUNE, India ... a new report by Allied Market Research, titled, "Global Cancer ... the global revenue of cancer biomarkers market is projected to ... at a CAGR of 13.3% from 2016 to 2022. Omic ... share in 2015 and is expected to maintain its dominance ...
Breaking Medicine Technology: